What one share of 10x Genomics holds
Our mission is to accelerate the mastery of biology to advance human health. We are a life sciences technology company focused on building innovative products and solutions to interrogate, understand and master biology. Our integrated research solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology.
10x Genomics’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $4.85 |
|---|---|
| Profit | −$0.59 |
| Capex (buildings and equipment) | $0.04 |
| Free cash flow | $0.96 |
| Cash and investments | $3.87 |
| Book value | $6.35 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $6.13 | −$1.62 | $0.32 | −$1.25 | — | −$9.71 |
| 2018 | $10.93 | −$8.40 | $0.47 | −$6.17 | — | −$15.12 |
| 2019 | $6.29 | −$0.80 | $1.09 | −$0.21 | — | — |
| 2020 | $2.95 | −$5.37 | $0.36 | −$2.52 | — | $6.81 |
| 2021 | $4.44 | −$0.53 | $0.92 | −$1.11 | — | $7.27 |
| 2022 | $4.54 | −$1.46 | $1.16 | −$1.45 | — | $6.99 |
| 2023 | $5.28 | −$2.18 | $0.41 | −$0.54 | — | $6.22 |
| 2024 | $5.07 | −$1.52 | $0.10 | −$0.05 | — | $5.81 |
| 2025 | $5.15 | −$0.35 | $0.05 | $1.04 | — | $6.24 |
Common questions about 10x Genomics
How much does one share of 10x Genomics earn?
Over the last 12 months, 10x Genomics lost $0.59 for each share on $4.85 of sales.
Does 10x Genomics pay a dividend?
10x Genomics didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is 10x Genomics’s book value per share?
10x Genomics’s book value is $6.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of 10x Genomics have?
Each share of 10x Genomics has $3.87 of cash and investments, as of June 30, 2026.
What is 10x Genomics’s free cash flow per share?
$0.96 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has 10x Genomics bought back shares?
10x Genomics’s share count rose about 977% from 2017 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.